Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

INTRODUCTION: Scabies is a significant contributor to global morbidity, affecting approximately 200 million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lake, Susanna J, Phelan, Sophie L, Engelman, Daniel, Sokana, Oliver, Nasi, Titus, Boara, Dickson, Gorae, Christina, Schuster, Tibor, Grobler, Anneke C, Osti, Millicent H, Andrews, Ross, Marks, Michael, Whitfeld, Margot J, Romani, Lucia, Kaldor, John, Steer, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462236/
https://www.ncbi.nlm.nih.gov/pubmed/32868360
http://dx.doi.org/10.1136/bmjopen-2020-037305

Ejemplares similares

Ejemplares similares